Phase III, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy for (Induction of Remission) and Safety of Etrolizumab Compared with Placebo in Patients with Moderate to Severe Ulcerative Coliti
|Effective start/end date||1/1/19 → 12/31/21|
- Genentech Inc.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.